Aquatic Capital Management LLC Allakos Inc. Transaction History

Aquatic Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.3 - $8.27 $30,530 - $58,717	-7,100 Reduced 94.67%	400 $2,000
Q4 2022 Feb 14, 2023	BUY	$5.66 - $8.42 $42,450 - $63,150	7,500 New	7,500 $63,000
Q2 2022 Aug 15, 2022	BUY	$2.6 - $6.14 $11,960 - $28,244	4,600 New	4,600 $14,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $108M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.